In Vitro Effects of Tp5 Analogs on E-Rosette Formation and Cell Division
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 9 (1), 1-18
- https://doi.org/10.3109/08923978709035198
Abstract
The effects of seventeen synthetic analogs of thymopentin (TP-5) have been studied in the active and azathioprine-inhibited E-rosette tests. Thymopentin was gradually shortened from the C terminus to peptides and single amino acids. Thymopoietin 32-34 (Arg-Lys-Asp-RGH-0205-TP-3) (II) and thymopoietin 32-35 (Arg-Lys-Asp-Val-RGH-0206-TP-4) (I) were the most active peptides. Dipeptide Arg-Lys produced significant stimulatory effect on azathioprine (ED75) inhibited E-receptor. Treatment of azathioprine (ED75-inhibited E-rosette forming cells (ERFC) with arginine or especially lysine increased the number of ERFC. Some of TP-4 analogs decreased further the number of ERFC decreased by azathioprine ED30. These “suppressive” peptides as well as TP-3 caused a partial arrest of K 562 cell proliferation up to 96 hours. Results suggest that TP-5 is not the smallest active fragment of thymopoietins, since peptides (TP-3 and TP-4) exhibit similar or higher T-cell membrane activation on E-receptor. Arginine, lysine, and acidic aspartyl residue seem to be a necessary basic structure to produce a cumulative chemical signal on the activity of T-lymphocytes.Keywords
This publication has 28 references indexed in Scilit:
- Deficient natural killer function in patients receiving immunosuppressive drugs: Analysis at the cellular levelCellular Immunology, 1984
- Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytesCellular Immunology, 1983
- Therapeutic use of TP5 (thymopoietin 32–36) in sarcoidosis of the skinClinical Immunology and Immunopathology, 1983
- THYMOPOIETIN PENTAPEPTIDE TREATMENT OF PRIMARY IMMUNODEFICIENCIESThe Lancet, 1983
- Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 1982
- Monoclonal antibodies OKT 11 and OKT 11A have pan‐T reactivity and block sheep erythrocyte “receptors”European Journal of Immunology, 1982
- Functional and Developmental Compartments of Human T LymphocytesVox Sanguinis, 1980
- Immunokinetics of a Single Dose of Thymopoietin PentapeptideJournal of Immunopharmacology, 1980
- Synthesis and effects of two peptide fragments of thymopoietin II on E-rosette forming cells in the uremic state.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- LYMPHOCYTE DIFFERENTIATION FROM PRECURSOR CELLS IN VITRO*Annals of the New York Academy of Sciences, 1975